Literature DB >> 26944165

Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28.

Andrea Mignarri1, Anna Rubegni2, Alessandra Tessa2, Stefano Stefanucci3, Alessandro Malandrini1, Elena Cardaioli1, Maria Chiara Meschini2, Maria Laura Stromillo1, Stefano Doccini2, Antonio Federico1, Filippo Maria Santorelli4, Maria Teresa Dotti1.   

Abstract

Mutations in DDHD1 cause the SPG28 subtype of hereditary spastic paraplegia (HSP). Recent studies suggested that mitochondrial dysfunction occurs in SPG28. Here we describe two siblings with SPG28, and report evidence of mitochondrial impairment in skeletal muscle and skin fibroblasts. Patient 1 (Pt1) was a 35-year-old man with spastic paraparesis and urinary incontinence, while his 25-year-old brother (Pt2) had gait spasticity and motor axonal neuropathy. In these patients we identified the novel homozygous c.1429C>T/p.R477* mutation in DDHD1, using a next-generation sequencing (NGS) approach. Histochemical analyses in muscle showed mitochondrial alterations, and multiple mitochondrial DNA (mtDNA) deletions were evident. In Pt1, respiratory chain enzyme activities were altered in skeletal muscle, mitochondrial ATP levels reduced, and analysis of skin fibroblasts revealed mitochondrial fragmentation. It seems possible that the novel nonsense mutation identified abolishes DDHD1 protein function thus altering oxidative metabolism. Qualitative alterations of mtDNA could have a pathogenetic significance. We suggest to perform DDHD1 analysis in patients with multiple mtDNA deletions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DDHD1; Hereditary spastic paraplegia; Mitochondrial disease; SPG28

Mesh:

Substances:

Year:  2016        PMID: 26944165     DOI: 10.1016/j.jns.2016.02.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Widening the Heterogeneity of Leigh Syndrome: Clinical, Biochemical, and Neuroradiologic Features in a Patient Harboring a NDUFA10 Mutation.

Authors:  Francesca Minoia; Marta Bertamino; Paolo Picco; Mariasavina Severino; Andrea Rossi; Chiara Fiorillo; Carlo Minetti; Claudia Nesti; Filippo Maria Santorelli; Maja Di Rocco
Journal:  JIMD Rep       Date:  2017-03-01

Review 2.  Lipid-metabolizing serine hydrolases in the mammalian central nervous system: endocannabinoids and beyond.

Authors:  Myungsun Shin; Timothy B Ware; Hyeon-Cheol Lee; Ku-Lung Hsu
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-16       Impact factor: 4.698

3.  The Spastic Paraplegia-Associated Phospholipase DDHD1 Is a Primary Brain Phosphatidylinositol Lipase.

Authors:  Jordon M Inloes; Hui Jing; Benjamin F Cravatt
Journal:  Biochemistry       Date:  2018-09-17       Impact factor: 3.162

4.  Ddhd1 knockout mouse as a model of locomotive and physiological abnormality in familial spastic paraplegia.

Authors:  Takuya Morikawa; Hiroaki Ohishi; Kengo Kosaka; Tomofumi Shimojo; Akihiro Nagano; Itsuki Taniguchi; Ryuta Fujioka; Kosei Moriyama; Motoko Unoki; Masatomo Takahashi; Motonao Nakao; Yoshihiro Izumi; Takeshi Bamba; Hiroyuki Sasaki; Shiroh Miura; Hiroki Shibata
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

5.  A Novel Missense Mutation of the DDHD1 Gene Associated with Juvenile Amyotrophic Lateral Sclerosis.

Authors:  Chujun Wu; Dongsheng Fan
Journal:  Front Aging Neurosci       Date:  2016-12-06       Impact factor: 5.750

6.  Spastic paraplegia-linked phospholipase PAPLA1 is necessary for development, reproduction, and energy metabolism in Drosophila.

Authors:  Martina Gáliková; Peter Klepsatel; Judith Münch; Ronald P Kühnlein
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

Review 7.  Lipid metabolic pathways converge in motor neuron degenerative diseases.

Authors:  Olivia J Rickman; Emma L Baple; Andrew H Crosby
Journal:  Brain       Date:  2020-04-01       Impact factor: 13.501

8.  Zbtb16 regulates social cognitive behaviors and neocortical development.

Authors:  Noriyoshi Usui; Stefano Berto; Ami Konishi; Makoto Kondo; Genevieve Konopka; Hideo Matsuzaki; Shoichi Shimada
Journal:  Transl Psychiatry       Date:  2021-04-24       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.